- Home
- RMCF vs OSRH Comparison
RMCF vs OSRH Comparison
Compare RMCF & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCF
- OSRH
- Stock Information
- Founded
- RMCF 1981
- OSRH N/A
- Country
- RMCF United States
- OSRH United States
- Employees
- RMCF N/A
- OSRH N/A
- Industry
- RMCF Specialty Foods
- OSRH
- Sector
- RMCF Consumer Staples
- OSRH
- Exchange
- RMCF Nasdaq
- OSRH Nasdaq
- Market Cap
- RMCF 11.4M
- OSRH 11.1M
- IPO Year
- RMCF N/A
- OSRH N/A
- Fundamental
- Price
- RMCF $2.14
- OSRH $0.72
- Analyst Decision
- RMCF
- OSRH
- Analyst Count
- RMCF 0
- OSRH 0
- Target Price
- RMCF N/A
- OSRH N/A
- AVG Volume (30 Days)
- RMCF 755.1K
- OSRH 13.9M
- Earning Date
- RMCF 10-14-2025
- OSRH 08-14-2025
- Dividend Yield
- RMCF N/A
- OSRH N/A
- EPS Growth
- RMCF N/A
- OSRH N/A
- EPS
- RMCF N/A
- OSRH N/A
- Revenue
- RMCF $29,545,000.00
- OSRH $104,735.00
- Revenue This Year
- RMCF N/A
- OSRH N/A
- Revenue Next Year
- RMCF N/A
- OSRH N/A
- P/E Ratio
- RMCF N/A
- OSRH N/A
- Revenue Growth
- RMCF 5.81
- OSRH N/A
- 52 Week Low
- RMCF $1.12
- OSRH $0.45
- 52 Week High
- RMCF $3.49
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- RMCF 77.32
- OSRH 52.10
- Support Level
- RMCF $1.64
- OSRH $0.57
- Resistance Level
- RMCF $2.05
- OSRH $0.76
- Average True Range (ATR)
- RMCF 0.13
- OSRH 0.07
- MACD
- RMCF 0.06
- OSRH 0.02
- Stochastic Oscillator
- RMCF 94.81
- OSRH 50.90
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.